Omnibus Waiver, Consent and Amendment Sample Contracts

Omnibus Waiver, Consent, Notice and Amendment

Omnibus Waiver, Consent and Amendment • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Omnibus Waiver, Consent and Amendment
• Filed
  May 21st, 2024
• Company
  MyMD Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Omnibus Waiver, Consent and Amendment (this “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).